全文获取类型
收费全文 | 54681篇 |
免费 | 4643篇 |
国内免费 | 1367篇 |
专业分类
耳鼻咽喉 | 237篇 |
儿科学 | 1128篇 |
妇产科学 | 1149篇 |
基础医学 | 5105篇 |
口腔科学 | 1053篇 |
临床医学 | 6454篇 |
内科学 | 11048篇 |
皮肤病学 | 403篇 |
神经病学 | 847篇 |
特种医学 | 709篇 |
外国民族医学 | 11篇 |
外科学 | 2897篇 |
综合类 | 7691篇 |
一般理论 | 1篇 |
预防医学 | 8727篇 |
眼科学 | 226篇 |
药学 | 6922篇 |
12篇 | |
中国医学 | 1565篇 |
肿瘤学 | 4506篇 |
出版年
2024年 | 35篇 |
2023年 | 759篇 |
2022年 | 1148篇 |
2021年 | 2179篇 |
2020年 | 1981篇 |
2019年 | 1881篇 |
2018年 | 1820篇 |
2017年 | 1862篇 |
2016年 | 2016篇 |
2015年 | 2358篇 |
2014年 | 3792篇 |
2013年 | 4691篇 |
2012年 | 3933篇 |
2011年 | 4131篇 |
2010年 | 3179篇 |
2009年 | 2916篇 |
2008年 | 3060篇 |
2007年 | 2982篇 |
2006年 | 2569篇 |
2005年 | 2149篇 |
2004年 | 1810篇 |
2003年 | 1412篇 |
2002年 | 1126篇 |
2001年 | 1029篇 |
2000年 | 815篇 |
1999年 | 685篇 |
1998年 | 538篇 |
1997年 | 520篇 |
1996年 | 436篇 |
1995年 | 377篇 |
1994年 | 356篇 |
1993年 | 266篇 |
1992年 | 254篇 |
1991年 | 221篇 |
1990年 | 156篇 |
1989年 | 159篇 |
1988年 | 115篇 |
1987年 | 128篇 |
1986年 | 95篇 |
1985年 | 134篇 |
1984年 | 90篇 |
1983年 | 55篇 |
1982年 | 86篇 |
1981年 | 68篇 |
1980年 | 57篇 |
1979年 | 46篇 |
1978年 | 29篇 |
1977年 | 41篇 |
1976年 | 38篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 26 毫秒
1.
《Indian journal of medical microbiology》2022,40(4):516-520
PurposeThe spread of infections caused by Enterobacterales strains resistant to carbapenems is a global public health problem, and early detection of carbapenemases is very important to prevent their spread. The rapid detection of carbapenemase production with the new commercial assay Rapidec® Carba NP test is based on the biochemical detection of imipenem hydrolysis. Our study aims to evaluate the performance of the Rapidec® Carba NP test in OXA-48 positive isolates highly prevalent in our country and also in isolates with more than one carbapenemase gene that have an increased prevalence and to examine whether it can be used for confirmation of carbapenemase positivity in the routine laboratory.MethodsA total of 97 strains of 94 carbapenem-resistant Klebsiella pneumoniae and three carbapenem-resistant Escherichia coli isolated from various clinical specimens were included in the study. The results of the Rapidec® Carba NP assay were compared with those obtained by the multiplex PCR test.ResultsThe sensitivity of the Rapidec® Carba NP test was 97.8% for all carbapenemase-positive isolates. Of 90 PCR positive isolates, one OXA-48 and one OXA-48 ?+ ?NDM positive isolates were negative with Rapidec® Carba NP test.ConclusionsThe positive results detected by the Rapidec® Carba NP test make an important contribution to the early detection of carbapenemase production and infection control practices. Since two carbapenemase positive isolates were found to be negative with the Rapidec® Carba NP test in our study, it was concluded that negative results of carbapenem-resistant isolates obtained with this assay should be confirmed with an additional carbapenemase detection method to exclude false-negative results. 相似文献
2.
《Research in microbiology》2022,173(3):103901
Infections caused by Klebsiella pneumoniae are often difficult to manage due to the high frequency of multidrug resistance, often conferred by efflux pumps. In this study, we analyzed sequence variations of the major RND family multidrug efflux pump AcrB from 387 assembled K. pneumoniae genomes. We confirm that AcrB is a highly-conserved efflux pump in K. pneumoniae, and identified several variants that were prevalent in clinical isolates. Molecular dynamics analyses on two of these variants (L118M and S966A) suggested conformational changes that may correlate with increased drug efflux capabilities. The L118M change resulted in enhanced protein rigidity while the flexibility of drug binding pockets was stable or increased, and the interactions between the proximal pockets and water molecules were stronger. For S966A, the significantly enlarged proximal pocket suggested higher drug accommodation ability. Consistent with these predictions, the L118M and S966A variants conferred a slightly increased ability to grow in the presence of tetracycline and to survive cefoxitin exposure when overexpressed. In summary, our results suggest that the emergence of enhanced-function AcrB variants may be a potential risk for increased antibiotic resistance in clinical K. pneumoniae isolates. 相似文献
3.
《The Journal for Nurse Practitioners》2022,18(2):140-146
Early detection and improved treatments for breast cancer are increasing survival rates, thereby growing the number of survivors to almost 4 million in the United States. Continuing care after treatment is frequently provided in primary care. Evidence-based care includes a history review, physical examination, and imaging for recurrence and new cancers, along with health maintenance and health promotion. Additionally, survivors often experience long-term side effects from their disease and/or treatment, affecting health and quality of life. This article provides a synopsis of breast cancer treatment-related side effects and current evidence-based guidelines to assist the primary care provider caring for survivors. 相似文献
4.
目的 建立妊娠11~13+6周子宫动脉多普勒参数在低危人群中的正常参考值,同时评估其对不良妊娠结局的预测价值。方法 收集2019年6月至2021年6月于我院行产前超声检查的妊娠11~13+6周孕妇,根据妊娠结局分组。收集两侧子宫动脉多普勒指标,包括搏动指数(PI)、阻力指数(RI)、舒张早期是否有切迹,以及孕妇基本临床资料和胎儿出生信息,将以上相关参数进行统计学分析。结果 最终纳入800例孕妇,包括正常妊娠结局组740例和不良妊娠结局组60例。两组孕妇体质量指数(BMI)、分娩孕周和胎儿出生体质量比较,差异均有统计学意义(均P<0.05)。随着孕周的增加,子宫动脉两侧平均搏动指数(mPI)、平均阻力指数(mRI)和两侧舒张早期切迹检出率均呈逐渐下降的趋势。ROC曲线分析显示,mPI、mRI及两侧舒张早期切迹预测妊娠结局的曲线下面积(AUC)分别为0.542、0.574、0.521,三者联合预测妊娠结局的AUC为0.648;孕妇BMI、年龄mPI、mRI及两侧舒张早期切迹预测妊娠结局的AUC为0.751。结论 建立了低危人群在妊娠11~13+6周子宫动脉多普勒参数的正常参考值范围。在妊娠11~13+6周单纯应用子宫动脉多普勒参数预测妊娠结局的价值有限,将子宫动脉参数与临床相关指标结合可提高对不良妊娠结局的预测价值。 相似文献
5.
6.
《Drug discovery today》2022,27(4):1108-1114
This project demonstrates the use of the IEEE 2791–2020 Standard (BioCompute Objects [BCO]) to enable the complete and concise communication of results from next generation sequencing (NGS) analysis. One arm of a clinical trial was replicated using synthetically generated data made to resemble real biological data and then two independent analyses were performed. The first simulated a pharmaceutical regulatory submission to the US Food and Drug Administration (FDA) including analysis of results and a BCO. The second simulated an FDA review that included an independent analysis of the submitted data. Of the 118 simulated patient samples generated, 117 (99.15%) were in agreement in the two analyses. This process exemplifies how a template BCO (tBCO), including a verification kit, facilitates transparency and reproducibility, thereby reinforcing confidence in the regulatory submission process. 相似文献
7.
8.
9.
10.